Low-energy Auger and conversion electrons deposit their energy in a very small volume (a few nm 3 ) around the site of emission. From a radiotoxicological point of view the effects of low-energy electrons on normal tissues are largely unknown, understudied, and generally assumed to be negligible. In this context, the discovery that the low-energy electron emitter, 99m Tc, can induce stunning on primary thyrocytes in vitro, at low absorbed doses, is intriguing. Extrapolated in vivo, this observation suggests that a radioisotope as commonly used in nuclear medicine as 99m Tc may significantly influence thyroid physiology. The aims of this study were to determine whether 99m Tc pertechnetate ( 99m TcO 4 2 ) is capable of inducing thyroid stunning in vivo, to evaluate the absorbed dose of 99m TcO 4 2 required to induce this stunning, and to analyze the biological events associated/concomitant with this effect. Our results show that 99m TcO 4 2 -mediated thyroid stunning can be observed in vivo in mouse thyroid. The threshold of the absorbed dose in the thyroid required to obtain a significant stunning effect is in the range of 20 Gy. This effect is associated with a reduced level of functional Na/I symporter (NIS) protein, with no significant cell death. It is reversible within a few days. At the cellular and molecular levels, a decrease in NIS mRNA, the generation of double-strand DNA breaks, and the activation of the p53 pathway are observed. Low-energy electrons emitted by 99m Tc can, therefore, induce thyroid stunning in vivo in mice, if it is exposed to an absorbed dose of at least 20 Gy, a level unlikely to be encountered in clinical practice. Nevertheless this report presents an unexpected effect of low-energy electrons on a normal tissue in vivo, and provides a unique experimental setup to understand the fine molecular mechanisms involved in their biological effects.
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Introduction
Thyroid stunning is a clinical problem in which exposure of a patient to diagnostic amounts of 131 I has been described to alter the ability of differentiated thyroid carcinoma, or remnants of thyroid tissue after thyroidectomy, to take up therapeutic, irradiating doses of 131 I [1, 2, 3, 4, 5] . Although widely documented in the literature, the reality and existence of this phenomenon are questioned by many clinicians [5] . Some experts advocate that the so-called stunning effect is in fact the consequence of an early destruction of the target tissues by an excessive amount of radiotracer used for a diagnostic purpose [5] . In this clinical context, basic scientific studies using cultured, polarized thyroid epithelial cells in vitro have recently produced clear and convincing evidence of the existence of a stunning effect and of its mechanism [6, 7, 8, 9, 10] . These studies demonstrated that irradiation of the cell culture via 131 I uptake resulted in a significant reduction in basalto-apical iodide transport, even at low absorbed doses. This effect reached a 50% reduction in iodide transport at an absorbed dose of around 1.5 Gy and was observed with no evidence of cell death [7] . Using the same experimental setup, the same group demonstrated that 131 I-induced stunning could be explained by a decrease in the mRNA level of the Na/I symporter (NIS), the transmembrane protein involved in the iodide uptake by the thyroid [8] . More recently, the same group published an intriguing study in which the ''stunning efficacies'' of 131 I, 123 I, 99m Tc and 211 As were compared in the same cell culture system [9] . Experiments were designed to deliver a ''standardized'' absorbed dose of 0.5 Gy from these radioisotopes, which are all accumulated in thyroid cells via a NIS-dependent mechanism. The results showed that all of these radioisotopes were capable of reducing iodide transport by decreasing NIS mRNA levels a few days later. The ''stunning power'' of 131 I appeared to be poorer than that of 123 I or even 99m Tc in this setting. Although the absorbed dose-rate resulting from the relative half-life and radiation type of these different isotopes may be partially responsible for the difference in biological activity observed, these results are puzzling. Extrapolated in vivo, this study suggests that a radioisotope as commonly used in nuclear medicine as 99m Tc may significantly influence thyroid biology. In addition, SPECT/CT imaging of ectopic NIS gene expression with 99m TcO 4 2 has been validated at the preclinical level and is starting to be used in the clinic to determine the kinetics of gene transfer in gene therapy [11, 12, 13, 14] . Hence, the conditions required to induce a 99m TcO 4 2 -mediated thyroid stunning effect in vivo need to be clarified. The stunning effect of 99m Tc is attributed to low-energy electrons.
The energy of low-energy electrons is deposited in a very small volume (a few nm 3 ) around the site of de-excitation of radionuclides such as 123 I, 125 I, 111 In, or 99m Tc [15, 16] . In biology, these electrons are thought to have played a significant role as mutagenic agents in evolution [17] and today they represent the basis of attractive strategies for new, targeted cancer treatments [16] . In the latter approaches, Auger electron emitters (typically 125 I or 111 In) are incorporated into small molecules [18] , peptides [19] , proteins [20, 21] or antibodies [22] capable of targeting cancer cell nuclei, where Auger electrons will exert their irradiating effects. From a radiotoxicological point of view, however, the effects of Auger electrons on normal, nonpathological biological systems are largely unknown, understudied and generally assumed to be negligible [23] .
The aims of the present study were to determine whether 99m TcO 4 2 was capable of inducing stunning in vivo, to evaluate the absorbed dose of 99m TcO 4 2 required to induce this stunning, and to analyze the biological events associated/concomitant with this effect.
Materials and Methods

Animals
Female, eight-week-old Balb/c mice were obtained from Janvier (Le Genest Saint Isle, France). Animal housing and procedures were conducted according to the French Agriculture Ministry guidelines and were approved by the local ethics committee (CIEPAL: Comité Institutionnel d'Ethique Pour l'Animal de Laboratoire) (Permit number # A06-088-14-138). Animals were fed using a standard regimen with a normal-iodide diet, except for two animals included in the protocol for dosimetric calculations that received an iodide-poor regimen for 8 days before the study (see below).
In vivo MicroSPECT/CT Studies 99m Tc pertechnetate ( 99m TcO 4 2 ) was obtained from a freshly eluted 99 Mo/ 99m Tc generator. Animals were administered intraperitoneally with 99m TcO 4 2 activities ranging from 10 MBq to 150 MBq. Thyroid tracer uptake was measured 60 minutes later using a dedicated microSPECT/CT scanner (eXplore speCZT CT120, GE) under gas anesthesia (air and 1-2% isoflurane) in an air-warmed imaging chamber (Minerve, Esternay, France) to keep body temperature constant at 37uC. The SPECT scanner uses a [24] . Reconstructed images were analyzed and quantified using AMIDE software [25] . Tracer activity in the thyroid was calculated by converting the total image units measured in a 3D region of interest to MBq using the calibration factor. Thyroid uptake was expressed as percentage of the injected dose (%ID) after decay correction, except for dosimetric calculations (see Figure 1B) .
Animal Study Protocols
For dosimetric calculations, thyroid SPECT imaging was repeated 1, 3 and 7 hours after intraperitoneal administration of 150 MBq 99m TcO 4 2 in four mice. Two mice had a standardregimen diet, two had a poor-iodide-regimen diet for 8 days before the study. This dietary manipulation is known to lead to different thyroid 99m TcO 4 2 uptake capacity and was used to establish a correspondence between absorbed dose to the thyroid (at 24 hours) and thyroid activity at the peak.
To determine the early effect of an initial administration of 99m TcO 4 2 on thyroid uptake, 21 animals that received 25 MBq (n = 3), 100 MBq (n = 3) or 150 MBq (n = 15) were imaged again 24 hours after the initial SPECT, using a standard (50 MBq) 99m TcO 4 2 activity. To investigate the later impact of the administration of 99m TcO 4 2 on the thyroid uptake, 12 animals initially received 150 MBq tracer, resulting in an absorbed dose to the thyroid of 27.564.1 Gy, ranging from 20.4 to 35.7 Gy. The animals were imaged again 1 (n = 3), 2 (n = 3), 4 (n = 3) or 8 days (n = 3) later, using a standard 99m TcO 4 2 activity (50 MBq). After the end of the second scan, the animals were culled and, when relevant, biopsies of different organs were collected.
Dosimetry
The absorbed dose in the thyroid (in Gy) was estimated based on the MIRD formalism [26] . The cumulated activity in the thyroid (Bq.s) was calculated based on quantitative imaging and multiplied by the thyroid self S-value (Gy.Bq Figure 1B . Activities were not corrected for nuclear decay. Cumulated activity was calculated for each mouse, using a linear fitting model for the uptake phase, and a mono-exponential fitting model for the washout, both implemented in Root software (http://root.cern.ch). No activity was considered at t = 0 and the endpoint for cumulated activity calculation was taken at t = 24 hours.
S-values were calculated based on the realistic-digital-mouse (Moby) whole-body phantoms (version 2), representing a 16-weekold male C57BL/6 mouse [27] . We generated a 22 g mouse model as a 3D rectangular matrix of cubic voxels (20062006200 mm   3 ). The final 3D image dataset was composed of 25665506256 voxels and saved in a raw format (16-bit; unsigned integer; little-endian; 72 MB). Thyroid mass was reduced to 5.4 mg by applying an erode mask implemented on ImageJ software. Soft tissues, lungs, bones and air density, and material composition [28] were also taken into account for radiation transport purposes.
S-values were calculated using Monte Carlo modeling of radiation transport and energy deposition in the voxel-based mouse model. Up to 10 6 particles were simulated using GATE (version 6.1), based on the GEANT4 toolkit (version 9.04 patch01), both of which are well-established codes for radiation transport [29, 30, 31] .
The voxel-based mouse was implemented with the CompressedMatrix option, the most suited function available for dosimetric purposes in that version, and regions of interest were defined using the range option. Physics List Standard Option 3 was used to define physics processes. The deposited energy was scored at the voxel level of the phantom with the DoseActor, doseDistributionEdep. Statistical uncertainties were calculated using the associated UncertaintyEdep option. GATE was run with Mersenne Twister [32] .
The thyroid self S-value was calculated for 99m Tc. All detailed photon and electron emissions were based on the ''MIRD radionuclide data and decay schemes'' [33] . Cubic spline interpolation was applied to all continuous energy spectra used in simulations. The source was assumed to be distributed homogeneously within the thyroid and statistical uncertainties in self S-values were kept below 1%.
Membrane Vesicle Preparation And SDS-PAGE Analyses
Thyroid membrane proteins were obtained as previously described [34] and subjected to SDS-PAGE electrophoresis. Western blotting was performed with antibody 25 anti-mouse NIS, an affinity-purified rabbit immunoreactive serum fraction, as previously described [35] , an anti-Ser139 phospho H2AX mouse monoclonal Ab (Millipore, France), or with an anti-b-actin antibody (Sigma).
RNA Extraction, Quantitative RT-PCR and Microarrays
Extraction of total RNA from mouse thyroid, and quantitative RT-PCR, were performed as previously described [36, 37, 38] . Relative mRNA expression levels were determined using DCt values obtained by subtracting Ct control (mouse actin) from Ct target gene (mouse NIS), and expressed using the comparative CT method (2 2DCT ). For microarray analysis, RNA samples were labeled with Cy3 dye using the Low RNA Input QuickAmp Kit (Agilent), as recommended by the supplier. Labeled cRNA probes (400 ng) were hybridized on 8660K high-density SurePrint G3 gene mouse GE 8660K Agilent microarrays. Four biological replicates were performed for each experimental condition. The experimental data are deposited in the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under the record number, GSE46470. Normalization of microarray data was performed using the Limma package (http://www.bioconductor.org). Interslide normalization was performed using the quantile methods. Means of ratios from 99m Tc-treated versus control tissues were calculated and B-test analysis was performed. Differentially expressed genes were selected based on an adjusted p value of 0.05. Data from expression microarrays were analyzed for enrichment in biological themes (Gene Ontology molecular function and canonical pathways) and biological networks were built using Ingenuity Pathway Analysis software (http://www. ingenuity.com/) and Mediante [39] .
Histology/Immunohistochemistry
Formalin-fixed, paraffin-embedded thyroid and salivary gland tissue sections were stained with hematoxylin/eosin for morphologic evaluation. Mouse NIS and phospho-Histone H2AX immunostaining were performed using a rabbit polyclonal anti99m TcO 4 2 -Mediated Thyroid Stunning NIS antibody (antibody 25, see [35] ) and an anti-Ser139 phospho H2AX rabbit mAb (Cell Signalling, France), followed by HRPconjugated anti-rabbit antibodies and the avidin-biotin complex immunoperoxidase method, respectively. Apoptosis (TUNEL) staining was performed using the pro-TUNEL assay kit (Euromedex, France). The sections were analyzed by a certified veterinary pathologist.
Statistical Analysis
Dual comparisons were made using the Student's t-test and comparisons between multiple conditions were analyzed using ANOVA. Statistical significance was set at p,0.05. Figure 1A presents typical, volume-rendered, fused SPECT/CT images in anterior and lateral views of the thyroid region. 99m TcO 4 2 is accumulated in the thyroid (red) and the salivary gland (blue-green). To measure precisely the thyroid 99m TcO 4 2 content, regions-of-interest excluding the salivary glands were drawn around the entire thyroid. The kinetics of 99m TcO 4 2 uptake and release in the thyroid were measured by SPECT/CT on live, anesthetized mice, 60 minutes, three hours, and seven hours after intraperitoneal administration of 150 MBq 99m TcO 4 2 . Figure 1B shows that the radioisotope content in the thyroid reaches its maximal value within one hour after 99m TcO 4 2 injection, thereafter decreasing progressively to reach near-basal levels at an estimated time of 8 hours. To enrich the dataset, we performed a similar experiment on animals that were fed on a poor-iodide diet. Accumulation of 99m TcO 4 2 in the thyroid followed the same overall pattern ( Figure 1B ) but the value at the peak averaged 6.5 MBq with a low-iodide diet while it averaged 3.5 MBq in mice fed a normal-iodide diet. Dosimetric calculations based on these pharmacokinetic data are detailed in Material S1. They indicate that the thyroid self S-value was 4.55E
Results
Dosimetric calculations
210
Gy.Bq
21
.s 21 . In these experimental conditions, the peak activity measured in the thyroid (ranging from 3 to 7 MBq) was strongly correlated (R 2 = 0.985) with the cumulated activity, and hence with the absorbed dose to the thyroid at 24 hours (range 18.9 to 49.6 Gy) ( Figure 1C ). Based on these kinetics and calculations, SPECT/CT analyses of thyroid activity throughout the study were systematically performed 60 minutes after radioisotope adminis- 99m TcO 4 2 uptake in the thyroid was measured by SPECT/CT in 12 mice at day 0 (D0) and again at day 1 (D1, n = 3), day 2 (D2, n = 3), day 4 (D4, n = 3), or day 8 (D8, n = 3). The second scan was performed by injecting a dose of 50 MBq Figure 1D ).
Dosimetric Requirement For 99m
TcO 4 2 -Mediated Thyroid Stunning Figure 2 shows that the threshold of initial absorbed dose required to observe a significant reduction (p = 0.048) in the capacity of the thyroid to take up 99m TcO 4 2 one day later was 22 Gy. In animals that received less than 22 Gy, the average decrease in 99m TcO 4 2 uptake was 3.95%, while in animals that received more than 22 Gy it was 17.5%.
Kinetics of 99m TcO 4 2 -mediated thyroid stunning
Using longitudinal follow up of individual mouse thyroids by SPECT/CT imaging, we next determined whether the 99m TcO 4 2 -mediated stunning was reversible. Thyroid activity was measured at day 0, upon administration of 150 MBq of 99m TcO 4 2 , resulting in an absorbed dose to the thyroid of 30 Gy, and reassessed after reinjection of 99m TcO 4 2 , at either day 1, 2, 4, or 8. Figure 3 shows that a single 30 Gy irradiation of the thyroid reduced the magnitude of 99m TcO 4 2 thyroid uptake by 45% at 24 hours. This impairment in thyroid uptake was observed for up to two days and the ability of the gland to take up the radiotracer was completely restored four days after the initial administration of 99m TcO 4 2 . These data demonstrate that the stunning is rapidly reversible.
Effect of 99m Tc exposure on NIS protein-and mRNA expression
NIS mRNA levels in mouse thyroid glands were measured 24 hours after a single exposure to 99m TcO 4 2 ( Figure 4A ). Expression was high in untreated thyroids but was downregulated by 2.5-fold (P = 0.0007) and 12-fold (P = 0.003) after exposure to 20 Gy and 30 Gy, respectively. In contrast, absorbed doses of 5 Gy failed to induce any significant reduction in the messenger levels. In addition, no marked variation was measured in the mRNA levels of the housekeeping gene, b-actin, measured in the same RNA preparation. To assess whether the reduction in NIS mRNA was associated with the irradiation induced by 99m TcO 4 2 or to a pharmacological effect of 99 Tc, we injected mice with a solution of 150 MBq 99m TcO 4 2 that had been left to decay for three days (about 12 periods). In these conditions, we estimate that the activity of 99m TcO 4 2 injected is 0.04 MBq, leading to an 8mGy irradiation of the thyroid. In these conditions, most of the technetium is in the form of 99 Tc. Although 99 Tc is radioactive, its half-life is very long (211000) years and we can consider that during the course of the experiment (1 day) the irradiation from 99 Tc is negligible. As expected, injection of a three-days decayed solution of 99m TcO 4 2 failed to affect the level of NIS mRNA ( Figure 4B ), suggesting that the stunning induced by 99m TcO 4 2 is dependent on irradiation.
Western blot analyses of NIS protein expression were performed using membrane preparations from mouse thyroids, 24 hours after a single exposure to 30 Gy 99m TcO 4 2 . Figure 4C shows a marked reduction in the amount of all functional NIS forms, including the higher molecular weight species likely to correspond to multimers and dimers as well as the monomers (90 kDa), compared with control tissues. Although not functional by itself, the 15 kDa band corresponding to the small C-terminal fragment of mNIS [35] was also markedly reduced. Re-expression of all functional NIS 
Histologic analysis of 99m TcO 4 2 -exposed thyroids
Hematoxylin-eosin-stained sections of 99m TcO 4 2 -exposed thyroids (absorbed dose of 30 Gy) showed normal thyroid histology, with intact colloid-containing follicles comparable with those of control mice, with no microscopic signs of cytotoxicity ( Figure 5A ). As a positive control, administration of a therapeutic dose of 131 I (500 Gy to the thyroid for 24 hours) was used. In this latter condition, the interstitium appears to be expanded by the infiltration of inflammatory cells not present in control or 99m TcO 4 2 -exposed thyroids (Figures 5B). To detect whether these exposures were associated with apoptosis, TUNEL staining was performed. Figure 5C shows a very similar situation in control thyroids and thyroids from 99m TcO 4 2 -exposed animals. By contrast, a strong nuclear TUNEL staining is observed on thyroid sections obtained from mice injected with 500 Gy 131 I ( Figure 5C ). More specifically, analysis of 10 randomly-selected fields showed 8 TUNEL-positive nuclei in control thyroids, 9 TUNEL-positive nuclei in 99m TcO 4 2 -exposed thyroids and more than 100 TUNEL-positive nuclei in 131 I-exposed thyroids. These results, combined with the observation that 99m TcO 4 2 -mediated thyroid stunning is recovered within five days of the initial exposure to the radioelement, strongly suggest an absence of significant destruction of the thyroid in response to 99m TcO 4 2 exposure.
Induction of double-strand DNA break repair in 99m TcO 4 2 -exposed thyroids
We next assessed whether exposure to 99m TcO 4 2 could lead to the induction of double-strand DNA break repair within the thyroid by following the level of phosphorylation of histone-2AX (cH2AX) [40] . A dose-dependent histone-2AX phosphorylation was detected, by Western blot, on extracts obtained from mouse thyroids subjected to 5, 20 and 30 Gy ( Figure 6A ). This observation was confirmed by immunohistochemistry ( Figure 6B ). Foci of nuclear cH2AX immunostaining were visible in sections generated from thyroid sections exposed to 30 Gy. To determine whether the presence of double-strand breaks is dependent on the uptake of the radioisotope by the cells, we next looked at the foci of nuclear cH2AX immunostaining in the salivary glands. In these glands, NIS is selectively expressed in the epithelial cells lining the ducts ( Figure 6B ) and cH2AX immunostaining was only detected in the nuclei of these ductal cells. This observation strongly suggests that the presence of double-strand breaks is dependent on the uptake of 99m TcO 4 2 by the cells.
Global pattern of gene expression in thyroids of 99m TcO 4 2 -exposed versus control mice
To determine the impact of 99m TcO 4 2 exposure on the thyroid, total RNA, extracted from four untreated thyroids and four thyroids exposed to 30 Gy with 99m TcO 4 2 , was analyzed using whole genome mouse microarrays. Total RNA was collected 24 hours after radioisotope administration. The comparison between these two conditions showed a significant modulation of (Table S1 and Figure 7 ). These transcripts efficiently discriminated 99m TcO 4 2 -exposed from control thyroids. As expected from the data presented in Figure 4 , NIS (Slc5a5) mRNA appeared to be among the most significantly downregulated transcripts in 99m TcO 4 2 -exposed cells, while Pax8, a transcription factor regulating NIS, appeared to be unaffected ( Figure 7 ). Gene ontology analysis using the Mediante information system [39] and Ingenuity Pathway TM showed a very strong association of these modulated transcripts with ''p53 signaling'' (P = 1.4610210) (Table S2 ). Several genes regulated by p53 were strongly upregulated in 99mTcO42-exposed thyroids, including cyclin-dependent kinase inhibitor, p21 (p21/Cdkn1a/Waf1/ Cip1), reprimo/p53-dependent G2 arrest mediator candidate (Rprm), BCL2-associated X protein (Bax), p53 E3 ubiquitin protein ligase (Mdm2) and members of the TNF receptor family, Fas (Apo-1, Apt1, CD95, Fas1, Fastm, Tnfrsf6) (Table S2) .
Discussion
The first aim of this study was to determine whether 99m TcO 4 2 was capable of inducing stunning, in vivo, in mouse thyroid glands. Our data show that an irradiation above 22 Gy via 99m TcO 4 2 accumulation in the thyroid leads, in the vast majority of cases, to a marked reduction (up to 40%) in the ability of the thyroid to take up the same radioisotope 24 hours later. This stunning effect, induced by a single injection of 99m TcO 4 2 , could be observed for up to two days, and the ability of the thyroid to accumulate the radiotracer was completely recovered four days after the initial uptake by the thyroid, independent of any significant tissue destruction. The reversibility of this stunning within a few days confirms this hypothesis. The kinetics of residence of the radioisotope were determined by analysis of SPECT/CT images. Pharmacokinetic data showed that the peak 99m TcO 4 2 content in the thyroid was reached within 1 hour after intraperitoneal injection and strongly correlated with the cumulated dose at 24 hours. These data are in agreement with the previously published biodistribution of 99m TcO 4 2 measured by direct counting of radioactivity in biopsies collected at different times from different animals [41] . Our dataset highlights the fact that small-animal SPECT imaging is a very powerful tool, capable of generating reliable data, whilst minimizing the number of experimental animals. Dosimetric calculations revealed that the 99m TcO 4 2 -mediated thyroid stunning effect requires an absorbed dose in the thyroid in the range of 20 Gy, observed in animals injected with an activity of 150 MBq. Activities from 74 to 370 MBq 99m TcO 4 2 are administered to patients during routine thyroid examination, leading to an absorbed dose to the thyroid below 20 mGy (Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy, http://interactive.snm.org/docs/ Thyroid_Scintigraphy_V3.pdf). This large difference in absorbed dose to the thyroid between humans and mice can be explained by the larger volume of distribution of the radioisotope in humans. In addition, all mouse thyrocytes are reported to express NIS, while its expression in human thyrocytes is only patchy [42] . Thus, although 99m TcO 4 2 -mediated thyroid stunning is a real phenomenon in mice, it is very unlikely to be encountered in clinical practice.
The biological events associated/concomitant with 99m TcO 4 2 -mediated stunning were studied by comparing the global pattern of gene expression in the thyroid glands of 99m TcO 4 2 -exposed versus control mice. Several genes were found to be up-or downregulated (see Table S1 ). Amongst these, the NIS gene (slc5a5) was the most highly downregulated. This result is intriguing as the most downregulated gene encodes the protein responsible for the radioisotope uptake, and therefore for the irradiation of the cell. This phenomenon bears the hallmark of an adaptive response of the thyroid to irradiation. Analysis of the whole dataset indicates, with a very high statistical significance (P value in the range of 10 216 ), that the variation in gene expression observed in the thyroids of 99m TcO 4 2 -exposed animals is the result of activation of the p53 pathway. This pathway is typically activated when cells are subjected to stress [43] . In our case, the stress is irradiation of the cells with an absorbed dose in the range of 20 Gy. A similar stress response was reported in thyroids subjected to 11 Gy 211 At [44] . However, in this latter study NIS gene expression was not reported to vary, suggesting a differential regulation of NIS expression in thyroid cells subjected to a particles and to low-energy electrons.
The 99m TcO 4 2 -mediated irradiation led to the induction of double-strand DNA break repair. Foci of nuclear cH2AX staining were already visible in sections generated from thyroids exposed to 5 Gy, their numbers increased in sections from thyroids exposed to 30 Gy. In the salivary glands, NIS is expressed in ductal epithelial cells, and cH2AX nuclear foci are only detectable in these structures. The salivary gland dataset demonstrates that the biological events triggered by 99m TcO 4 2 exposure happen selectively in NIS-expressing cells capable of accumulating the radiotracer. The requirement for 99m TcO 4 2 to enter the cell in order to provoke maximal DNA damage and, if the dose is high enough, cell death, has been demonstrated in vitro using the NISexpressing PCCl3 thyroid cell line [45, 46, 47, 48] . In these experiments, 99m TcO 4 2 -mediated toxicity was clearly magnified by 99m TcO 4 2 entry into the cells [45, 46, 47] and was further enhanced by 99m TcO 4 2 retention [48] . This increased radiotoxicity from intracellular 99m Tc is likely to be the result of an increased dose deposition in cellular structures due to Auger and conversion electrons, with low range and high local energy deposition properties. The biological effects observed upon internal irradiation of the thyrocytes (double-strand DNA breaks, p53 pathway activation, decrease in NIS protein and mRNA content) may be triggered by a direct or indirect action of lowenergy electrons. These mechanisms may not be mutually exclusive and could be involved to different degrees in the different biological events triggered by low-energy electrons. A direct mechanism implies that 99m TcO 4 2 enters the nucleus and is in direct contact with DNA. Alternatively, following the deexcitation of 99m TcO 4 2 nuclides in the cell, low-energy electrons may trigger the production of reactive oxygen species (ROS), which could induce the observed biological effects. These ROS could induce DNA damage and activate the p53 pathway. Considering that ROS have already been shown in vitro to decrease NIS mRNA levels and reduce iodide uptake [49] , ROS may have a preponderant role in 99m TcO 4 2 -mediated thyroid stunning.
In conclusion, we demonstrate in this report that 99m TcO 4 2 -mediated thyroid stunning can be observed in vivo in mouse thyroid. This effect is not associated with significant cell death and is reversible within a few days. At the cellular level, decreased NIS mRNA, p53 pathway activation, and the generation of doublestrand DNA breaks can be observed. However, considering that the thyroid needs to be exposed to an absorbed dose of at least 20 Gy for a significant stunning, this effect is unlikely to be encountered in clinical practice. Nevertheless, from a biological point of view our system provides a unique experimental setup to compare the sensitivities of different NIS-expressing organs to lowenergy electrons and to understand the fine molecular mechanisms involved in cellular stunning. 4 2 -exposed thyroids. Affected canonical pathways ordered by p-value are presented. The probability of obtaining the number of genes in a certain pathway in the list of differentially expressed genes was compared with the representation of the same pathway among all the genes on the microarray; -log10 of the Fisher's exact probability is indicated. (DOCX) Material S1 Dosimetric calculations.
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